Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 12
Submit an article Journal homepage
440
Views
13
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Decitabine in myelodysplastic syndromes and chronic myelomonocytic leukemia: Argentinian/South Korean multi-institutional clinical experience

Marcelo IastrebnerSan Luis Medical Center, Buenos Aires, ArgentinaCorrespondence[email protected]
,
Jun Ho JangDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
,
Elsa NuciforaHematology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
,
Kihyun KimDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
,
Federico SackmannHematology, Fundaleu, Buenos Aires, Argentina
,
Dong Hwan KimDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
,
Sergio OrlandoHospital Rossi CACAIBA, La Plata, Argentina
,
Chul Won JungDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
,
Ana BasquieraHospital Privado, Córdoba, Argentina
,
Graciela KleinHospital Rossi CACAIBA, La Plata, Argentina
,
Fernando SantiniHospital Privado Comunidad, MAr del Plata, Argentina
,
Haydee I. BernardHematology, Hospital Ramón Madariaga, Posadas, Argentina
,
Jorge KorinConsultorios Hematológicos, Buenos Aires, Argentina
&
Gustavo TabordaPoliclinico Modelo, Cipoletti, Argentina
 show all
Pages 2250-2257 | Received 15 Apr 2010, Accepted 13 Sep 2010, Published online: 07 Oct 2010

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Drorit G Merkel & Arnon Nagler. (2013) The role of hypomethylating agents in myelodysplastic syndrome: changing the management paradigm. Expert Review of Hematology 6:6, pages 665-676.
Read now

Articles from other publishers (12)

Hui Liu, Hao Jiang, Hongyan Tong, Ruixiang Xia, Linhua Yang, Hongguo Zhao, Jian Ouyang, Hai Bai, Hui Sun, Li Hou, Ming Jiang, Yun Zeng, Zhuogang Liu, Aibin Liang, Yinghua Xie, Kang Yu, Zhimin Zhai, Li Liu, Jinsong Jia, Rong Fu & Zonghong Shao. (2023) Decitabine in patients with myelodysplastic syndromes: A multi‐center, open‐label, dose comparison trial. Cancer Medicine 12:13, pages 13885-13893.
Crossref
Li Ye, Yanling Ren, Xinping Zhou, Chen Mei, Weilai Xu, Liya Ma, Yingwan Luo, Chao Hu, Xingnong Ye, Juying Wei, Yinjun Lou, Jie Jin & Hongyan Tong. (2019) Decitabine improves overall survival in myelodysplastic syndromes-RAEB patients aged ≥60 years and has lower toxicities: Comparison with low-dose chemotherapy. Blood Cells, Molecules, and Diseases 77, pages 88-94.
Crossref
Raphael Itzykson, Pierre Fenaux, David Bowen, Nicholas C.P. Cross, Jorge Cortes, Theo De Witte, Ulrich Germing, Francesco Onida, Eric Padron, Uwe Platzbecker, Valeria Santini, Guillermo F. Sanz, Eric Solary, Arjan Van de Loosdrecht & Luca Malcovati. (2018) Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults. HemaSphere 2:6, pages e150.
Crossref
Bo Yang, Ruili Yu, Lili Cai, Xiaohua Chi, Cui Liu, Lei Yang, Xueyan Wang, Peifeng He & Xuechun Lu. (2017) A comparison of therapeutic dosages of decitabine in treating myelodysplastic syndrome: a meta-analysis. Annals of Hematology 96:11, pages 1811-1823.
Crossref
Li Ye, Yanling Ren, Xinping Zhou, Chen Mei, Liya Ma, Xingnong Ye, Juying Wei, Weilai Xu, Haitao Meng, Wenbin Qian, Wenyuan Mai, Yinjun Lou, Gaixiang Xu, Jiejing Qian, Yejiang Lou, Yingwan Luo, Lili Xie, Peipei Lin, Chao Hu, Jie Jin & Hongyan Tong. (2017) Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone. Journal of Cancer Research and Clinical Oncology 143:5, pages 873-882.
Crossref
Seongseok Yun, Nicole D. Vincelette, Ivo Abraham, Keith D. Robertson, Martin E. Fernandez-Zapico & Mrinal M. Patnaik. (2016) Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials. Clinical Epigenetics 8:1.
Crossref
Xiao Li, Qiang Song, Yu Chen, Chunkang Chang, Dong Wu, Lingyun Wu, Jiying Su, Xi Zhang, Liyu Zhou, Luxi Song, Zheng Zhang, Feng Xu & Ming Hou. (2014) Decitabine of Reduced Dosage in Chinese Patients with Myelodysplastic Syndrome: A Retrospective Analysis. PLoS ONE 9:4, pages e95473.
Crossref
Shyamala C. Navada, Juliane Steinmann, Michael Lübbert & Lewis R. Silverman. (2014) Clinical development of demethylating agents in hematology. Journal of Clinical Investigation 124:1, pages 40-46.
Crossref
Michael Daskalakis, Tina E. Joeckel, Michael Lübbert & A. Kuendgen. 2014. Epigenetic Therapy of Cancer. Epigenetic Therapy of Cancer 145 170 .
Xiao Li, Chunkang Chang, Qi He, Feng Xu, Qingxia Zhang, Lingyun Wu, Jiying Su, Xi Zhang, Liyu Zhou, Dong Wu, Luxi Song & Zheng Zhang. (2013) Cytogenetic response based on revised IPSS cytogenetic risk stratification and minimal residual disease monitoring by FISH in MDS patients treated with low-dose decitabine. Leukemia Research 37:11, pages 1516-1521.
Crossref
Tina E. Joeckel & Michael Lübbert. (2012) Clinical Results With the DNA Hypomethylating Agent 5-Aza-2′-Deoxycytidine (Decitabine) in Patients With Myelodysplastic Syndromes: An Update. Seminars in Hematology 49:4, pages 330-341.
Crossref
Nelli Bejanyan, Ramon V. Tiu, Azra Raza, Ania Jankowska, Matt Kalaycio, Anjali Advani, Josephine Chan, Yogen Saunthararajah, Lindsey Mooney, Jaroslaw P. Maciejewski & Mikkael A. Sekeres. (2011) A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF). Cancer 118:16, pages 3968-3976.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.